FRANKLIN LAKES, N.J., Sept. 30, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its rapid, point-of-care, SARS-CoV-2 ...

MISSISSAUGA, ON, Nov. 10, 2020 /CNW/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its rapid, point-of-care, SARS-CoV-2 antigen test ...

As the world continues to have a need for COVID-19 testing, BD offers a reliable rapid antigen COVID-19 testing solution through the BD Veritor™ System for Rapid Detection of SARS-CoV-2*. This ...

The test is based on the company's BD Veritor Plus System, a handheld diagnostic device. The test is used in combination with the company's BD Veritor Plus System, a handheld electronic diagnostic ...

BD (Becton, Dickinson and Company), a leading global medical technology company, announced the receipt of an order from the Dutch Ministry of Health for 9.2 million of its rapid, point-of-care, ...

FRANKLIN LAKES, N.J. – USA Track & Field (USATF) and BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, have partnered to provide rapid COVID-19 testing for ...

Becton, Dickinson and Company BDX — also popularly known as BD — recently received CE mark for its rapid, point-of-care, SARS-CoV-2 antigen test for utilization on the BD Veritor Plus System. The new ...

Becton, Dickinson and Company BDX, popularly known as BD, received emergency use authorization (“EUA”) from the FDA for a new, rapid antigen test, which can simultaneously identify SARS-CoV-2, ...

SARS-CoV-2 Assay for BD Veritor™ Plus System to be available in Europe by end of October FRANKLIN LAKES, New Jersey, Sept. 30, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a ...

FRANKLIN LAKES, NJ and INDIANAPOLIS (Feb. 25, 2022) — USA Track & Field and BD, a leading global medical technology company, today announced the extension of BD’s sponsorship through 2022. As the ...